OBJECTIVE: To evaluate the hepatoprotective potential of Hepax, a polyherbal formulation, against three experimentally induced hepatotoxicity models in rats. METHODS: Hepatoprotective activity of Hepax was studied against three experimentally induced hepatotoxicity models, namely, carbon tetrachloride (CCl4), paracetamol and thiocetamide induced hepatotoxicity in rats. RESULTS: Administration of hepatotoxins (CCl4, paracetamol and thiocetamide) showed significant morphological, biochemical and histological deteriorations in the liver of experimental animals. Pretreatment with Hepax had significant protection against hepatic damage by maintaining the morphological parameters (liver weight and liver weight to organ weight ratio) within normal range and normalizing the elevated levels of biochemical parameters (SGPT, SGOT, ALP and total bilirubin), which were evidently showed in histopathological study. CONCLUSIONS: The Hepax has highly significant hepatoprotective effect at 100 and 200 mg/kg, p.o. on the liver of all the three experimental animal models.
OBJECTIVE: To evaluate the hepatoprotective potential of Hepax, a polyherbal formulation, against three experimentally induced hepatotoxicity models in rats. METHODS: Hepatoprotective activity of Hepax was studied against three experimentally induced hepatotoxicity models, namely, carbon tetrachloride (CCl4), paracetamol and thiocetamide induced hepatotoxicity in rats. RESULTS: Administration of hepatotoxins (CCl4, paracetamol and thiocetamide) showed significant morphological, biochemical and histological deteriorations in the liver of experimental animals. Pretreatment with Hepax had significant protection against hepatic damage by maintaining the morphological parameters (liver weight and liver weight to organ weight ratio) within normal range and normalizing the elevated levels of biochemical parameters (SGPT, SGOT, ALP and total bilirubin), which were evidently showed in histopathological study. CONCLUSIONS: The Hepax has highly significant hepatoprotective effect at 100 and 200 mg/kg, p.o. on the liver of all the three experimental animal models.
Authors: S Shyamal; P G Latha; S R Suja; V J Shine; G I Anuja; S Sini; S Pradeep; P Shikha; S Rajasekharan Journal: Singapore Med J Date: 2010-04 Impact factor: 1.858
Authors: Hartmut Jaeschke; Gregory J Gores; Arthur I Cederbaum; Jack A Hinson; Dominique Pessayre; John J Lemasters Journal: Toxicol Sci Date: 2002-02 Impact factor: 4.849
Authors: Marcel Petreanu; Paula Maia; Janieire L da Rocha Pittarello; Lucimara C Loch; Franco Delle Monache; Alice L Perez; Godofredo Solano-Arias; Valdir Cechinel Filho; Márcia Maria de Souza; Rivaldo Niero Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 2019-04-13 Impact factor: 3.000
Authors: Solange Bandiera; Rianne R Pulcinelli; Fernanda Huf; Felipe B Almeida; Graziele Halmenschlager; Paula E R Bitencourt; Eliane Dallegrave; Marilda C Fernandes; Rosane Gomez; Mauricio S Nin Journal: Toxicol Res Date: 2020-08-13